Clinical Trials Browser

Phase 2 × Active not recruiting × Mesothelioma, Malignant × Clear all

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT01843374 2026-03-05

Tremelimumab

Phase 2 Active not recruiting

571 enrolled 19 charts

Other solid neoplasmThoracic

Diabetes Mellitus, Insulin-Dependent, 12, Mesothelioma, Malignant

NCT02399371 2025-06-11

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Phase 2 Active not recruiting

65 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT04287829 2024-11-05

PEMMELA

Phase 2 Active not recruiting

58 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT04300244 2024-02-29

NIPU

Phase 2 Active not recruiting

118 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma, Neoplasms

Clinical Trials

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Tremelimumab

Pembrolizumab in Treating Patients With Malignant Mesothelioma

PEMMELA

NIPU